蛋白酶体对血管平滑肌细胞凋亡及表型转换调节作用的研究进展
摘要
蛋白酶体是广泛存在于真核细胞的一种蛋白复合物,负责降解泛素分子标记的蛋白,为细胞内清除体内异常合成及损坏蛋白的重要机制之一。此外,还通过蛋白合成的转录后调解参与多种重要的细胞功能,如抗原提呈、细胞周期的调节及转录活化因子NF-KB激活等^[1]。近期研究提示蛋白酶体在心血管系统的发育分化中发挥重要作用,同时在动脉粥样硬化、血管损伤后再狭窄、心肌肥大、心肌缺血-再灌注损伤等心血管疾病中发挥重要作用,
出处
《中华普通外科杂志》
CSCD
北大核心
2014年第3期235-237,共3页
Chinese Journal of General Surgery
参考文献25
-
1Hasselgren PO, Fischer JE. The ubiquitin-proteasome pathway : review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions [ J ]. Ann Surg, 1997,225(3) :307-316.
-
2Willis MS, Townley-Tilson WH, Kang EY, et al. Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease[J]. Cire Res, 2010,106 ( 3 ) :463-478.
-
3Kisselev AF, Garcia-Calvo M, Overkleeft HS, et al. The caspase- like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites [ J ]. J Biol Chem, 2003,278 ( 38 ) : 35869-35877.
-
4Mearini G, Schlossarek S, Willis MS, et al. The ubiquitin- proteasome system in cardiac dysfunction [ J ]. Biochim Biophys Acta, 2008,1782(12) :749-763.
-
5Herrmann J, Edwards WD, Holmes DR Jr, et al. Increased ubiquitin immunoreactivity in unstable atherosclerotic plaquesassociated with acute coronary syndromes [ J ]. J Am Coll Cardiol, 2002,40 ( 1 l ) : 1919-1927.
-
6Herrmann J, Saguner AM, Versar/ D, et al. Chronic proteasome inhibition contributes to coronary atherosclerosis [ J 1. Circ Res, 2007,101 ( 9 ) : 865-874.
-
7Marfella R, D'Amico M, Di Filippo C, et al. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment[ J]. J Am Coil Cardio, 2006,47 ( 12 ) :2444-2455.
-
8Demasi M, Laurindo FR. Physiological and pathological role of the ubiquitin-proteasome system in the vascular smooth muscle cell[J]. Cardiovasc Res, 2012,95(2) :183-193.
-
9Wang Q, Mora-Jensen H, Weniger MA, et al. ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells[J]. Proc Natl Acad Sci U S A, 2009,106(7) :2200-2205.
-
10Bhat UG, Halasi M, Gartel AL. FoxM1 is a general target for proteasome inhibitors[ J]. PLoS One, 2009,4 ( 8 ) : e6593.
二级参考文献22
-
1Nordon IM, Hinchliffe R J, Loftus IM, et al. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol, 2011,8:92-102.
-
2Jones KG, Brull DJ, Brown LC,et al. Interlcukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation, 2001, 103:2260-2265.
-
3Saraff K, Babamusta F, Cassis LA, et al. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin I1 -infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Bio1,2003,23 : 1621-1626.
-
4Forester ND, Cruickshank SM, Scott DJ, et al. Functional characterization of T cells in abdominal aortic aneurysms. Immunology, 2005,115:262-270.
-
5Sehonbeek U, Sukhova GK, Gerdes N, et al. Th2 predominant immune responses prevail in human abdominal aortic aneurysm. Am J Pathol, 2002,161:499-506.
-
6Ailawadi G, Eliason JL, Upchurch GR, Jr. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg, 2003,38:584-588.
-
7Boyle J J, Weissberg PL, Bennett MR. Tumor necrosis factor-ct promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler Thromb Vase Biol, 2003,23:1553-1558.
-
8Choke E, Thompson MM, Dawson J, et al. Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. Arterioseler Thromb Vase Bio1,2006 ,26 :2077-2082.
-
9Fortini ME. Notch signaling: the core pathway and its posttranslational regulation. Dev Cell,2009,16:633-647.
-
10Wang Z, Banerjee S, Li Y, et al. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-KB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res, 2006,66:2778-2784.
共引文献3
-
1焦阳,姜剑军.糖尿病对腹主动脉瘤保护机制的研究进展[J].中华普通外科杂志,2016,31(6):526-528.
-
2黄玉珍,温志茹.1例采用微创新技术救治急危重破裂腹主动脉瘤病人的护理[J].全科护理,2018,16(27):3455-3456.
-
3乔晓博,罗倩文,赵鹏,刘冉,王乐,吕晓,张明明.橘皮素通过抑制ERK1/2信号通路干预小鼠腹主动脉瘤的进展[J].心血管病学进展,2021,42(6):572-576. 被引量:2
-
1邹莉,张世鹰,卢芳国.麻黄在解表剂组方中的地位和用法的解析[J].时珍国医国药,2017,28(3):681-682. 被引量:3
-
2苑辉卿,娄红祥,薛克亮.水飞蓟素及其复合物的近期研究[J].国外医学(中医中药分册),1996,18(1):3-5. 被引量:16
-
3本刊通讯员.中药“雷公藤”红素抗癌机理被证实[J].中国中医药信息杂志,2006,13(6):38-38. 被引量:1
-
4王春玲,石宁,平小佳,刘艳琳,张宁,王明晓.蛋白酶体在动脉粥样硬化进展中的作用[J].中国医药导刊,2011,13(6):948-949.
-
5程彬彬.中药对糖皮质激素受体的调节研究概况[J].中国中医药信息杂志,2009,16(7):103-106. 被引量:3
-
6武超,刘平,孙明瑜,边艳琴.巨噬细胞亚群与肝病研究进展[J].世界华人消化杂志,2016,24(33):4491-4497.
-
7凃乾,梁艳,马骏,王述菊,沈峰,王彦春.电针对帕金森病模型大鼠中脑黑质蛋白酶体的影响[J].中国针灸,2015,35(4):355-360. 被引量:4
-
8李成浩,刘兰,金永日,金海燕,朴熙绪.草苁蓉提取物抑制HSC-T6细胞体外增殖及胶原合成[J].基础医学与临床,2012,32(6):715-716. 被引量:4
-
9刘云,包琼琼,庄晓赛,胡乔,孙妙璇,周莉莉,张雄.梓醇对乳胞素诱导SH-SY5Y细胞损伤的保护作用[J].中国药理学与毒理学杂志,2012,26(1):58-62. 被引量:4
-
10孙军,李岩.姜黄素对人肝癌细胞BEL-7402中HIF-1α表达的影响[J].中国药理学通报,2006,22(11):1379-1383. 被引量:15